Author Archives: Zuzanna Walter

The Children’s Mental Health Crisis: How Social Isolation in Childhood Alters Brain Development and Function 

Last month, the American Academy of Pediatrics (AAP), the American Academy of Child and Adolescent Psychiatry (AACAP), and Children’s Hospital Association declared a national emergency in children’s mental health. Exacerbated by the COVID-19 pandemic, mounting challenges across the spectrum of childcare have deepened disparities in pediatric primary care and are particularly evident in racial and ethnic minority groups. At the same time, pandemic conditions have led many children to lose their caregivers and forced them into increased social isolation – all of which has culminated in a mental health crisis among the youngest of the population.

Current statistics reveal the urgency of the problem at hand. According to the latest data from the Centers for Disease Control and Prevention, emergency department visits for mental health emergencies rose by 24% in children aged between 5 and 11 years and by 31% in children aged between 12 and 17 years during March through October of 2020. In early 2021, emergency department visits for suspected suicide attempts increased by 51% among girls aged between 12 and 17 years as compared to data from the same period in 2019.

Continue reading

Improving Stem Cell Treatment with Novel Drug Compound

One of the primary limitations of stem cell treatment and the subject of ongoing research is the challenge of directing stem cells to their necessary destination in the body which has been a subject of ongoing research. Prior studies have discovered that stem cells are drawn to inflammation in the body, however, using this as a therapeutic lure still poses risks. Thus, researchers continue their search for tools that would aid stem cells in their migration and conversion into specific types of cells necessary for optimal treatment. The ability to do so would have a wide range of implications for regenerative medicine as well as the treatment of disorders in which inflammatory signals fade over time, such as chronic spinal cord injury, stroke, or conditions in which the role of inflammation remains unknown.  Continue reading

Cognitive Behavioral Therapy for Insomnia 

Up to 32.5% of all adults in the United States report sleeping for less than seven hours per night on average despite needing between seven and nine hours of sleep. The problem of insomnia affects between 10% and 35% of adults, varying in duration, severity, and treatment outcomes. For some, insomnia can present as a brief problem while other patients may struggle with severe, chronic insomnia – both can have a negative effect on overall health, increasing the risk of mental health disorders, lowering quality of life, and raising blood pressure.

Sleeping medications are often prescribed to help patients resume a normal, healthy sleep schedule although these risk dependency and may lead to unwanted side effects. Cognitive behavioral therapy for insomnia, also known as CBT-I, is short, structured, and evidence-based approach to combating insomnia that can benefit the majority of patients with sleep problems. CBT-I can be beneficial for individuals with primary insomnia as well as those with chronic pain and mental health disorders.

Continue reading